Chris Wicker

Chris Wicker currently serves as the General Manager of the Pathology Division at Fulgent Genetics, overseeing laboratory and revenue cycle operations for several brands, including CSI, Therapath, and Inform Diagnostics. Previously, Chris was the Chief Executive Officer and Chief Financial Officer at CSI Laboratories, where a successful sale to Fulgent Genetics occurred in August 2021. Chris has held notable leadership roles in revenue cycle management, including Senior Director at Optum and Senior Vice President at Healthcare Solutions, contributing to significant sales and operational successes. Earlier career highlights include Vice President roles at ApolloMD and MedQuest Associates, focusing on reimbursement and operational finance in various healthcare settings. Chris holds a BBA in Accounting and Finance from Baylor University.